FDMT 4D Molecular Therapeutics, Inc.

Fundamentals / CIK 0001650648 / USD

4D Molecular Therapeutics, Inc. reported $96.06M in revenue and a net loss of $200.4M for the trailing twelve months ended September 30, 2026 (up 4505.6% year over year), with a -226.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open FDMT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$101.0M$50.48M$0-$157.7MFY 2019 Revenue: $6.99MFY 2019 Net Income: -$49.31M2019FY 2020 Revenue: $13.61MFY 2020 Net Income: -$56.69M2020FY 2021 Revenue: $18.04MFY 2021 Net Income: -$71.32M2021FY 2022 Revenue: $3.13MFY 2022 Net Income: -$107.5M2022FY 2023 Revenue: $20.72MFY 2023 Net Income: -$100.8M2023FY 2024 Revenue: $37KFY 2024 Net Income: -$160.9M2024FY 2025 Revenue: $85.21MFY 2025 Net Income: -$140.1M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $85.21M $37K $20.72M $3.13M $18.04M $13.61M $6.99M
Research & Development $195.7M $141.3M $97.10M $80.25M $61.36M $53.04M $38.72M
Total Operating Expenses $244.8M $187.9M $133.6M $113.2M $89.37M $70.28M $57.75M
Operating Income -$159.5M -$187.8M -$112.9M -$110.0M -$71.33M -$56.66M -$50.76M
EBITDA -$154.9M -$183.2M -$108.7M -$107.6M -$69.81M -$55.22M -$49.76M
Interest Income $19.48M $27.05M $12.21M $2.57M $137K $152K $1.50M
Income Tax Expense $0 $0 $0 $0 $0 $0 --
Net Income -$140.1M -$160.9M -$100.8M -$107.5M -$71.32M -$56.69M -$49.31M
Basic EPS -$2.42 -$2.98 -$2.58 -$3.32 -$2.57 -$8.82 -$9.59
Diluted EPS -$2.42 -$2.98 -$2.58 -$3.32 -$2.57 -$8.82 -$9.59
Basic Shares Outstanding 57.9M 53.9M 39.1M 32.4M 27.7M 6.4M 5.1M
Diluted Shares Outstanding 57.9M 53.9M 39.1M 32.4M 27.7M 6.4M 5.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $4.14M $3.78M $3.05M $85.09M $90K $15K $14K $1.0K
Research & Development $69.78M $68.28M $64.98M $57.61M $49.44M $47.95M $40.70M $43.09M
Total Operating Expenses $85.36M $80.81M $76.67M $70.38M $61.27M $59.47M $53.63M $56.12M
Operating Income -$81.22M -$77.03M -$73.62M $14.71M -$61.19M -$59.46M -$53.62M -$56.12M
EBITDA -$80.00M -$75.75M -$72.35M $15.93M -$59.92M -$58.29M -$52.57M -$55.02M
Interest Income $3.94M $4.25M $4.86M $4.70M $4.33M $4.86M $5.58M $6.47M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$78.06M -$72.94M -$68.76M $19.40M -$56.88M -$54.66M -$47.97M -$49.67M
Basic EPS -$1.08 -$1.04 -$1.01 -- -$1.01 -$0.98 -$0.86 --
Diluted EPS -$1.08 -$1.04 -$1.01 -- -$1.01 -$0.98 -$0.86 --
Basic Shares Outstanding 72.3M 70.3M 68.1M -- 56.1M 55.9M 55.7M --
Diluted Shares Outstanding 72.3M 70.3M 68.1M -- 56.1M 55.9M 55.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $60.24M $149.3M $249.1M $52.35M $153.0M $276.7M $49.65M
Short-Term Investments $342.4M $275.5M $39.12M $161.2M $94.78M $0 --
Cash & Short-Term Investments $514.0M $424.9M $288.2M $213.6M $247.8M $276.7M $49.65M
Accounts Receivable, Net -- -- -- $0 $47K $1.49M $978K
Total Current Assets $413.1M $434.9M $296.6M $220.5M $256.3M $282.7M $52.51M
Property, Plant & Equipment, Net $14.87M $19.53M $20.13M $22.26M $14.39M $5.07M $5.05M
Long-Term Investments $111.4M $80.58M $10.95M $4.91M $67.65M $0 --
Other Non-Current Assets $9.19M $4.26M $684K $1.08M $602K $602K $677K
Total Non-Current Assets $153.6M $125.5M $43.30M $41.34M $97.21M $5.67M $5.73M
Total Assets $566.7M $560.4M $339.9M $261.8M $353.5M $288.3M $58.23M
Accounts Payable $11.16M $4.39M $3.52M $3.32M $4.76M $1.79M $1.74M
Deferred Revenue (Current) $360K $257K $273K $884K $2.60M $6.59M $5.86M
Total Current Liabilities $43.98M $29.15M $18.95M $15.73M $16.34M $16.74M $12.96M
Long-Term Debt $0 -- -- -- -- -- --
Deferred Revenue (Non-Current) $745K $1.06M $972K $1.08M $2.49M $13.23M $13.60M
Other Non-Current Liabilities $138K $193K $248K $21K $120K $1.85M $1.56M
Total Non-Current Liabilities $17.06M $20.63M $13.11M $14.78M $18.04M $15.20M $15.27M
Total Liabilities $61.05M $49.78M $32.06M $30.51M $34.38M $31.94M $28.22M
Total Debt (incl. Leases) $21.41M $24.61M $14.67M $16.12M $16.45M -- --
Common Stock $6.0K $5.0K $4.0K $3.0K $3.0K $3.0K $1.0K
Retained Earnings -$716.3M -$576.2M -$415.3M -$314.5M -$207.0M -$135.7M -$79.03M
Accumulated Other Comp. Income $727K $229K $16K -$1.20M -$423K $0 --
Total Stockholders' Equity $505.7M $510.6M $307.8M $231.3M $319.1M $256.4M -$72.97M
Total Equity $505.7M $510.6M $307.8M $231.3M $319.1M $256.4M -$72.97M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $39.10M $70.37M $72.49M $60.24M $48.55M $77.16M $133.5M $149.3M
Short-Term Investments $267.9M $291.0M $318.4M $342.4M $256.5M $216.1M $187.9M $275.5M
Cash & Short-Term Investments $307.0M $361.3M $390.9M $514.0M $305.1M $293.2M $321.4M $424.9M
Total Current Assets $322.3M $383.0M $405.4M $413.1M $312.4M $303.3M $332.6M $434.9M
Property, Plant & Equipment, Net $11.22M $12.38M $13.59M $14.87M $16.15M $17.50M $18.75M $19.53M
Long-Term Investments $68.04M $69.30M $66.74M $111.4M $67.17M $123.8M $137.0M $80.58M
Other Non-Current Assets $11.44M $11.44M $9.86M $9.19M $9.38M $9.39M $7.04M $4.26M
Total Non-Current Assets $106.5M $109.7M $107.5M $153.6M $111.6M $170.3M $183.2M $125.5M
Total Assets $428.7M $492.6M $512.9M $566.7M $424.0M $473.6M $515.7M $560.4M
Accounts Payable $7.88M $12.52M $14.69M $11.16M $6.86M $8.70M $4.15M $4.39M
Deferred Revenue (Current) $360K $360K $360K $360K $360K $1.07M $866K $257K
Total Current Liabilities $52.39M $47.67M $43.40M $43.98M $37.11M $34.68M $26.90M $29.15M
Long-Term Debt $19.68M $19.59M -- $0 -- -- -- --
Deferred Revenue (Non-Current) $2.83M $2.96M $2.12M $745K $835K $219K $434K $1.06M
Other Non-Current Liabilities $2.08M $101K $121K $138K $144K $161K $177K $193K
Total Non-Current Liabilities $38.41M $37.28M $17.66M $17.06M $17.89M $18.07M $19.11M $20.63M
Total Liabilities $90.81M $84.96M $61.07M $61.05M $55.00M $52.75M $46.01M $49.78M
Total Debt (incl. Leases) $38.41M $39.22M $20.54M $21.41M $22.26M $23.08M $23.85M $24.61M
Common Stock $6.0K $6.0K $5.0K $6.0K $5.0K $5.0K $5.0K $5.0K
Retained Earnings -$936.1M -$858.0M -$785.1M -$716.3M -$735.7M -$678.8M -$624.2M -$576.2M
Accumulated Other Comp. Income -$1.00M -$446K -$180K $727K $671K $337K $332K $229K
Total Stockholders' Equity $337.9M $407.7M $451.8M $505.7M $369.0M $420.9M $469.7M $510.6M
Total Equity $337.9M $407.7M $451.8M $505.7M $369.0M $420.9M $469.7M $510.6M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$140.1M -$160.9M -$100.8M -$107.5M -$71.32M -$56.69M -$49.31M
Depreciation & Amortization $4.69M $4.65M $4.20M $2.40M $1.52M $1.44M $1.00M
Stock-Based Compensation $22.02M $26.12M $19.66M $17.12M $13.80M $4.98M $3.54M
Change in Receivables -- -- $0 $47K $1.44M -$508K $146K
Change in Payables $6.77M $871K $896K -$1.64M $2.29M $43K $533K
Operating Cash Flow -$109.1M -$134.6M -$75.79M -$86.69M -$69.13M -$50.91M -$36.71M
Capital Expenditure -$536K -$3.79M -$2.77M -$11.54M -$9.11M -$1.00M -$3.20M
Free Cash Flow -$109.6M -$138.4M -$78.56M -$98.22M -$78.24M -$51.91M -$39.91M
Purchases of Investments -$442.8M -$467.7M -$54.80M -$153.3M -$168.6M $0 --
Investing Cash Flow -$92.97M -$302.4M $115.7M -$17.05M -$172.7M -$1.00M -$3.20M
Common Stock Issued -- -- -- $0 $114.3M $205.7M --
Financing Cash Flow $113.0M $337.2M $156.8M $3.08M $118.1M $279.0M -$2.19M
Net Change in Cash -$89.09M -$99.77M $196.8M -$100.7M -$123.7M $227.1M -$42.11M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$78.06M -$72.94M -$68.76M $19.40M -$56.88M -$54.66M -$47.97M -$49.67M
Depreciation & Amortization $1.22M $1.28M $1.27M $1.22M $1.26M $1.17M $1.05M $1.10M
Stock-Based Compensation $8.26M $5.88M $4.45M $5.55M $4.52M $4.96M $6.99M $7.58M
Change in Payables -$2.94M -$4.06M $3.53M $4.30M -$1.84M $4.55M -$235K $1.46M
Operating Cash Flow -$56.71M -$70.00M -$68.12M $28.55M -$46.50M -$43.38M -$47.76M -$45.86M
Capital Expenditure -- -- -- $70K $91K -$66K -$631K -$949K
Free Cash Flow -- -- -- $28.62M -$46.41M -$43.44M -$48.39M -$46.81M
Purchases of Investments -$84.83M -$62.04M -$33.52M -$178.1M -$15.24M -$115.4M -$134.1M -$57.78M
Investing Cash Flow $24.84M $25.54M $68.89M -$128.8M $17.78M -$13.85M $31.95M $7.06M
Financing Cash Flow $604K $42.34M $11.48M $112.0M $116K $862K $0 $601K
Net Change in Cash -$31.27M -$2.12M $12.25M $11.69M -$28.60M -$56.37M -$15.81M -$38.20M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -187.2% -507678.4% -544.6% -3516.5% -395.5% -416.3% -726.7%
Net Profit Margin -164.4% -434778.4% -486.6% -3435.4% -395.4% -416.5% -705.8%
Return on Equity (ROE) -27.7% -31.5% -32.8% -46.5% -22.3% -22.1% --
Return on Assets (ROA) -24.7% -28.7% -29.7% -41.1% -20.2% -19.7% -84.7%
Current Ratio 9.39x 14.92x 15.65x 14.02x 15.69x 16.88x 4.05x
Quick Ratio 11.69x 14.58x 15.21x 13.58x 15.17x 16.62x 3.91x
Debt to Equity 0.04x 0.05x 0.05x 0.07x 0.05x -- --
Revenue Growth (YoY) +230194.6% -99.8% +562.3% -82.7% +32.5% +94.8% --
5Y Revenue / Share Growth -30.5% -99.9% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -226.0% -214.2% -203.5% -187.2% -191982.5% -667654.5% -884026.1% -507678.4%
Net Profit Margin -208.6% -194.7% -182.3% -164.4% -174314.2% -594375.8% -767126.1% -434778.4%
Return on Equity (ROE) -59.3% -44.0% -35.6% -27.7% -56.7% -46.6% -37.6% -31.5%
Return on Assets (ROA) -46.7% -36.4% -31.4% -24.7% -49.3% -41.4% -34.2% -28.7%
Current Ratio 6.15x 8.03x 9.34x 9.39x 8.42x 8.75x 12.36x 14.92x
Quick Ratio 5.86x 7.58x 9.01x 11.69x 8.22x 8.46x 11.95x 14.58x
Debt to Equity 0.11x 0.10x 0.05x 0.04x 0.06x 0.05x 0.05x 0.05x
Revenue Growth (YoY) +4505.6% +25106.7% +21664.3% +8508900.0% +2900.0% +200.0% -50.0% --
Source: SEC EDGAR CompanyFacts (CIK 0001650648) · from December 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:33 UTC · Open in terminal